Clinical Trial Update: Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase II clinical trial evaluating preoperative IMRT combined with capecitabine and bevacizumab for locally advanced recta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Locally Advanced Malignant Neoplasm | Phase 2 | Status: UNKNOWN